Skip to Content

J 58 (Lamivudine and Zidovudine 150 mg / 300 mg)

Pill with imprint J 58 is White, Capsule-shape and has been identified as Lamivudine and Zidovudine 150 mg / 300 mg. It is supplied by Aurobindo Pharma Limited.

Lamivudine/zidovudine is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Lamivudine/zidovudine 150 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for J 58

Lamivudine and Zidovudine

Imprint:
J 58
Strength:
150 mg / 300 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Aurobindo Pharma Limited
Inactive Ingredients:
silicon dioxide
hypromellose 2910 (6 mPa.s)
magnesium stearate
microcrystalline cellulose
polyethylene glycol 400
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0416 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide